Can Betamethasone Cream Be Used in Infants?
Betamethasone cream can be used in infants, but only with extreme caution due to the high risk of serious systemic adverse effects including HPA axis suppression, Cushing's syndrome, and growth retardation—it should be reserved for situations where less potent topical corticosteroids have failed, used in the smallest effective amount, for the shortest duration possible, and never under occlusive conditions like diapers.
Key Safety Concerns in Infants
Betamethasone is a potent topical corticosteroid that poses unique risks in the infant population:
Infants have a significantly higher skin surface area to body weight ratio, making them absorb proportionally larger amounts of topical corticosteroids and thus more susceptible to systemic toxicity 1.
Serious adverse effects documented in infants include HPA axis suppression, Cushing's syndrome, intracranial hypertension (bulging fontanelles, headaches, bilateral papilledema), linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to ACTH stimulation 1.
A case report documented severe iatrogenic Cushing's syndrome in an infant from betamethasone cream used for diaper rash, demonstrating considerable weight acceleration with concurrent height deceleration, hirsutism, facial ecchymosis, and buffalo hump 2.
Guideline-Based Approach to Topical Corticosteroid Selection in Infants
Start with low-potency agents first:
Infants and young children with atopic dermatitis should be treated with less potent topical corticosteroids because they have an increased risk of adrenal suppression from potent agents like betamethasone 3.
Low to medium potency topical corticosteroids (such as hydrocortisone or fluticasone) are the appropriate first-line choices for infants 3.
Potent corticosteroids should be avoided in infants unless absolutely necessary, and even then only after less potent options have failed 4.
When Betamethasone Might Be Considered (Rare Circumstances)
If betamethasone must be used in an infant:
Limit application to the least amount compatible with an effective therapeutic regimen 1.
Use for the shortest possible duration—chronic corticosteroid therapy may interfere with growth and development 1.
Avoid occlusive dressings entirely—parents must be advised not to use tight-fitting diapers or plastic pants in the treatment area, as these constitute occlusive dressings that dramatically increase systemic absorption 1.
Monitor for HPA axis suppression using urinary free cortisol tests and ACTH stimulation tests, especially when using potent steroids over large surface areas 1.
Critical Pitfalls to Avoid
Never use betamethasone in the diaper area where occlusion is unavoidable—this has resulted in documented cases of severe Cushing's syndrome 2.
Do not dilute betamethasone with base cream as a strategy to reduce potency—this controversial practice was documented in 32.4% of betamethasone prescriptions for infants in one audit, but it is not evidence-based and creates unpredictable dosing 5.
Avoid prescribing without clear instructions—frequency of dosing and length of therapy must be explicitly stated, as omission of these details occurred in 21.6% and 43.6% of prescriptions respectively in one study 5.
Watch for signs requiring immediate discontinuation: irritation, infection, or any manifestations of systemic absorption (growth changes, cushingoid features, behavioral changes) 1.
Practical Alternative Approach
For mild to moderate atopic dermatitis in infants:
- Use 1% hydrocortisone as first-line therapy 6.
- Regular liberal application of emollients has steroid-sparing effects 3.
- Short bursts (3 days) of a potent corticosteroid are equally effective as 7 days of mild preparation in children with mild-moderate eczema, but this applies to older children, not infants 6.